Education
About Us
Working with TipRanks
Follow Us
Protara Therapeutics (TARA)
NASDAQ:TARA
Protara Therapeutics (TARA) Ownership Overview
9.26% Insiders
5.11% Mutual Funds
40.16% Other Institutional Investors
6.98% ETFs
38.48% Public Companies and
Individual Investors
The ownership structure of Protara Therapeutics (TARA) stock is a mix of institutional, retail, and individual investors. Approximately 52.26% of the company’s stock is owned by Institutional Investors, 9.26% is owned by Insiders, and 38.48% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
May 16, 2025 | xxxxxxxxxxxxx | $63800 | |
Sep 12, 2024 | xxxxxxxxxxxxx | $270458 | |
Sep 10, 2024 | xxxxxxxxxxxxx | $113850 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2025 | xxxxxxxxxxxxx | $3149063 | |
Jun 30, 2025 | xxxxxxxxxxxxx | $5786275 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,989,134 | Insider | 5.16% | 6,027,076 | |
| 1,909,662 | Institution | 4.95% | 5,786,276 | |
| 1,552,659 | Institution | 4.02% | 4,704,557 | |
| 1,541,268 | Institution | 3.99% | 4,670,042 | |
| 1,039,295 | Institution | 2.69% | 3,149,064 | |
| 998,209 | Institution | 2.59% | 3,024,573 | |
| 959,886 | Insider | 2.49% | 2,908,455 | |
| 851,674 | Institution | 2.21% | 2,580,572 | |
| 536,832 | Institution | 1.39% | 1,626,601 | |
| 287,892 | Institution | 0.75% | 872,313 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,552,659 | Institution | 4.02% | 4,704,557 | |
| 287,892 | Institution | 0.75% | 872,313 | |
| 40,000 | Institution | 0.10% | 121,200 | |
| 29,769 | Institution | 0.08% | 90,200 | |
| 20,334 | Institution | 0.05% | 61,612 | |
| 16,636 | Institution | 0.04% | 50,407 | |
| 15,000 | Institution | 0.04% | 45,450 | |
| 8,141 | Institution | 0.02% | 24,667 | |
| 364 | Institution | <0.01% | 1,103 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,001,784 | Institution | 2.60% | 3,105,530 | |
| 642,845 | Institution | 1.67% | 1,947,820 | |
| 363,240 | Institution | 0.94% | 1,126,044 | |
| 279,921 | Institution | 0.73% | 848,161 | |
| 155,344 | Institution | 0.40% | 481,566 | |
| 75,443 | Institution | 0.20% | 228,592 | |
| 58,314 | Institution | 0.15% | 186,022 | |
| 20,900 | Institution | 0.05% | 64,790 | |
| 16,161 | Institution | 0.04% | 51,554 | |
| 15,358 | Institution | 0.04% | 46,535 |
FAQ
Who Owns Protara Therapeutics (TARA)?
According to the latest TipRanks data, approximately 40.16% of the company's stock is held by institutional investors, 9.26% is held by insiders, and 38.48% is held by retail investors.
What percentage of Protara Therapeutics (TARA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 40.16% of Protara Therapeutics (TARA) stock is held by institutional investors.
What percentage of Protara Therapeutics (TARA) stock is held by retail investors?
According to the latest TipRanks data, approximately 38.48% of Protara Therapeutics (TARA) stock is held by retail investors.
Who owns the most shares of Protara Therapeutics (TARA)?
Opaleye Management Inc. owns the most shares of Protara Therapeutics (TARA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.